Craig-Hallum analyst Eric Lauriers raised the firm’s price target on Goodness Growth (GDNSF) to 45c from 20c and keeps a Hold rating on the shares. Goodness Growth Holdings is a US cannabis multistate operator with a unique scientific and IP focus, the firm notes. The company is a market share leader in MN, a state with an increasingly robust medical program and an adult-use market that is set to start in 2025. Goodness Growthalso has strong exposure to recently legalized states of MD and NY, Craig-Hallum adds. However, the company’s growth plans were intimately tied to its acquisition by Verano (VRNOF), which was terminated by Verano in October 2022, with the two parties now in litigation.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GDNSF:
- CORRECTION – ACE Venture Enterprises, Inc. Announces Planned Acquisition of Vireo Health of New York from Goodness Growth Holdings
- ACE Venture Enterprises, Inc. Announces Planned Acquisition of Vireo Health of New York from Goodness Growth Holdings
- Goodness Growth Holdings Inc (GDNSF) Q4 Earnings Cheat Sheet
- Rising High: Exclusive talk with financial services firm Safe Harbor Financial
- Goodness Growth Holdings Reschedules Fourth Quarter and Full Year 2023 Results Call to April 1, 2024